Published in J Pharm Pharmacol on May 01, 1976
Fluvoxamine, a specific 5-hydroxytryptamine uptake inhibitor. Br J Pharmacol (1977) 2.10
Multiple regulatory sites in the Bacillus subtilis citB promoter region. J Bacteriol (1990) 1.40
[Recommendations for diagnosis, therapy and long-term management of patients with sleep apnea]. Med Klin (Munich) (1991) 1.40
The distribution of cholecystokinin immunoreactivity in the central nervous system of the rat as determined by radioimmunoassay. Brain Res (1981) 1.27
Influence of angiotensin, vasopressin or changes in flow rate on vasoconstriction, changes in volume and [3H]-noradrenaline release following postganglionic sympathetic nerve stimulation in the isolated cat spleen. Br J Pharmacol Chemother (1966) 1.20
Synthesis and release of prostaglandins by rat brain synaptosomal fractions. J Neurochem (1976) 1.17
Influence of isoproterenol, hydralazine and phentolamine on the renin activity of plasma and renal cortex of rats. Eur J Pharmacol (1970) 1.14
The importance of endogenous prostaglandins other than prostacyclin, for the modulation of contractility of some rabbit blood vessels. Br J Pharmacol (1984) 1.14
A study of the mechanism of the release of ATP from rat cortical astroglial cells evoked by activation of glutamate receptors. Neuroscience (1999) 1.09
Endocrine profile of a long-acting somatostatin derivative SMS 201-995. Study in normal volunteers following subcutaneous administration. Acta Endocrinol (Copenh) (1986) 1.04
Endogenous adenosine as a modulator of hippocampal acetylcholine release. Naunyn Schmiedebergs Arch Pharmacol (1984) 1.01
Protein kinase C activation and alpha 2-autoreceptor-modulated release of noradrenaline. Br J Pharmacol (1987) 1.01
Effect of dopamine receptor agonists and antagonists on release of dopamine in the rabbit caudate nucleus in vitro. Naunyn Schmiedebergs Arch Pharmacol (1978) 1.00
Neosynthesis and activation of Rho by Escherichia coli cytotoxic necrotizing factor (CNF1) reverse cytopathic effects of ADP-ribosylated Rho. J Biol Chem (1999) 0.99
Gabapentin augments whole blood serotonin in healthy young men. J Neural Transm (1988) 0.98
The role of endothelial and non-endothelial prostaglandins in the relaxation of isolated blood vessels of the rabbit induced by acetylcholine and bradykinin. Br J Pharmacol (1986) 0.97
Potentiation and abolition of the increase in plasma renin activity seen after hypotensive drugs in rats. Eur J Pharmacol (1972) 0.96
The mechanism of the drinking response to some hypotensive drugs: activation of the renin-angiotensin system by direct or reflex-mediated stimulation of -receptors. Naunyn Schmiedebergs Arch Pharmacol (1973) 0.96
Release of prostaglandins from isolated cat spleen by angiotensin and vasopressin. Naunyn Schmiedebergs Arch Pharmacol (1973) 0.95
Islet-activating protein (pertussis toxin) diminishes alpha 2-adrenoceptor mediated effects on noradrenaline release. Naunyn Schmiedebergs Arch Pharmacol (1985) 0.95
Cholecystokinin octapeptide in the rat hypothalamo-neurohypophysial system. Nature (1980) 0.94
A diurnal rhythm of incorporation of L-[3H] leucine in myocardium of the rat. Recent Adv Stud Cardiac Struct Metab (1975) 0.94
Effects of intracerebroventricular administration of prostaglandin D2 on behaviour, blood pressure and body temperature as compared to prostaglandins E2 and F2 alpha. Psychopharmacology (Berl) (1983) 0.94
Effect of prostaglandins D2, E2 and F2alpha on catecholamine release from slices of rat and rabbit brain. Eur J Pharmacol (1981) 0.94
Polymyxin B, a selective inhibitor of protein kinase C, diminishes the release of noradrenaline and the enhancement of release caused by phorbol 12,13-butyrate. Naunyn Schmiedebergs Arch Pharmacol (1986) 0.94
Gene expression of the small GTP-binding proteins RhoA, RhoB, Rac1, and Cdc42 in adult rat brain. Brain Res Mol Brain Res (1997) 0.93
Enhancement of noradrenaline release by 12-O-tetradecanoyl phorbol-13-acetate, an activator of protein kinase C. Eur J Pharmacol (1986) 0.91
Cerebral sarcoidosis presenting as supranuclear gaze palsy with hypokinetic rigid syndrome. Mov Disord (1989) 0.91
Are cerebral prostanoids of astroglial origin? Studies on the prostanoid forming system in developing rat brain and primary cultures of rat astrocytes. Brain Res (1987) 0.91
Adenosine: an endogenous modulator of hippocampal noradrenaline release. Neuropharmacology (1985) 0.91
Modulation by endogenous dopamine of the release of acetylcholine in the caudate nucleus of the rabbit. Naunyn Schmiedebergs Arch Pharmacol (1980) 0.91
Modulation of hippocampal serotonin (5-HT) release by endogenous adenosine. Eur J Pharmacol (1985) 0.90
Enhanced rate of expression and biosynthesis of neuropeptide Y after kainic acid-induced seizures. J Neurochem (1991) 0.90
Omega-conotoxin GVIA and pharmacological modulation of hippocampal noradrenaline release. Eur J Pharmacol (1988) 0.88
Regulation and glucocorticoid-independent induction of lipocortin I in cultured astrocytes. J Neurochem (1991) 0.88
[Inhibition by nephrectomy of drinking induced by hypotensive agents in rats]. Experientia (1971) 0.88
Simultaneous clinical manifestation of subependymoma of the fourth ventricle in identical twins. Case report. J Neurosurg (1979) 0.88
Effects of ruminal insufflation on renal function of conscious goats and calves. Am J Vet Res (1967) 0.87
Formation and elimination of prostacyclin metabolites in the cat in vivo as determined by radioimmunoassay of unextracted plasma. Eur J Pharmacol (1981) 0.87
EFNS guidelines on management of restless legs syndrome and periodic limb movement disorder in sleep. Eur J Neurol (2006) 0.87
The adenosine receptor-mediated inhibition of noradrenaline release possibly involves an N-protein and is increased by alpha 2-autoreceptor blockade. Br J Pharmacol (1987) 0.87
Protein kinase C and presynaptic modulation of acetylcholine release in rabbit hippocampus. Br J Pharmacol (1988) 0.86
Rebound insomnia after hypnotic withdrawal in insomniac outpatients. Eur Arch Psychiatry Clin Neurosci (1998) 0.86
Stimulation of receptors of gamma-aminobutyric acid modulates the release of cholecystokinin-like immunoreactivity from slices of rat neostriatum. Br J Pharmacol (1986) 0.86
Endogenous noradrenaline impairs the prostaglandin-induced inhibition of noradrenaline release. Naunyn Schmiedebergs Arch Pharmacol (1989) 0.86
Effects of gabapentin on release of gamma-aminobutyric acid from slices of rat neostriatum. Arzneimittelforschung (1993) 0.86
Role of vasopressin in the ACTH response to isoprenaline. Eur J Pharmacol (1982) 0.86
[Effect of various blood pressure-lowering drugs on water uptake and output in rats]. Naunyn Schmiedebergs Arch Pharmakol (1970) 0.86
Deafferentation studies on the glutamic acid decarboxylase content of the supraoptic nucleus of the rat. Brain Res (1980) 0.85
Effect of isoprenaline and trimethidinium on the plasma vasopressin concentration in conscious rats. Arch Int Pharmacodyn Ther (1980) 0.85
Effect of pretreatment with 6-hydroxydopamine on the uptake and metabolism of catecholamines by the isolated perfused rat heart. Br J Pharmacol (1971) 0.85
Comparison of the prostanoid synthesizing capacity in homogenates from primary neuronal and astroglial cell cultures. Biochem Pharmacol (1984) 0.84
[Pharmacokinetic studies on 3H-hexoprenaline in the rat]. Arzneimittelforschung (1973) 0.84
Uptake kinetics and metabolism of 7-3H-dopamine in the isolated perfused rat heart. Br J Pharmacol (1971) 0.84
Presynaptic kappa-opioid receptors on noradrenergic nerve terminals couple to G proteins and interact with the alpha 2-adrenoceptors. J Neurochem (1989) 0.84
False labelling of dopaminergic terminals in the rabbit caudate nucleus: uptake and release of [3H]-5-hydroxytryptamine. Br J Pharmacol (1986) 0.84
Inhibition of central neurotransmitter release by omega-conotoxin GVIA, a peptide modulator of the N-type voltage-sensitive calcium channel. Naunyn Schmiedebergs Arch Pharmacol (1987) 0.84
N-ethylmaleimide (NEM) diminishes alpha 2-adrenoceptor mediated effects on noradrenaline release. Naunyn Schmiedebergs Arch Pharmacol (1986) 0.84
On the relation between contraction and prostaglandin release in rabbit mesenteric blood vessels. Eur J Pharmacol (1980) 0.84
Domesticated farm animals in medical research. Ann N Y Acad Sci (1968) 0.84
The importance of Ca2+-mediated phospholipase A2 activation for stimulus-evoked PGE2-release from rabbit splenic capsular strips. Naunyn Schmiedebergs Arch Pharmacol (1979) 0.84
Inhibition of the transport of d-tubocurarine from blood to bile by k-strophantoside in the isolated perfused rat liver. Eur J Pharmacol (1968) 0.84
Adrenocorticotropin and beta-endorphin release from rat adenohypophysis in vitro: inhibition by prostaglandin E2 formed locally in response to vasopressin and corticotropin-releasing factor. Endocrinology (1984) 0.83
Differential expression of the small GTP-binding proteins RhoA, RhoB, Cdc42u and Cdc42b in developing rat neocortex. Brain Res Mol Brain Res (1999) 0.83
Evidence for the involvement of a GABA-mediated inhibition in the hypovolaemia-induced vasopressin release. Pflugers Arch (1980) 0.83
Role of dopamine receptors in the modulation of acetylcholine release in the rabbit hippocampus. Naunyn Schmiedebergs Arch Pharmacol (1982) 0.83
Serotonin (5-HT) enhances hippocampal noradrenaline (NA) release: evidence for facilitatory 5-HT receptors within the CNS. Naunyn Schmiedebergs Arch Pharmacol (1986) 0.83
Regional distribution of arachidonic acid metabolites in rat brain following convulsive stimuli. Prostaglandins (1981) 0.83
Endogenous noradrenaline as modulator of hippocampal serotonin (5-HT)-release. Dual effects of yohimbine, rauwolscine and corynanthine as alpha-adrenoceptor antagonists and 5-HT-receptor agonists. Naunyn Schmiedebergs Arch Pharmacol (1985) 0.83
Characterization of "high-affinity" [3H]ouabain binding in the rat central nervous system. J Neurochem (1985) 0.83
Origin of the cholecystokinin-containing fibers in the rat caudatoputamen. Science (1982) 0.83
Disturbance of eye movements in Huntington's chorea. Arch Psychiatr Nervenkr (1970) (1981) 0.83
Properties and the cytoskeletal control of Ca(++)-independent large conductance K+ channels in neonatal rat hippocampal neurons. J Membr Biol (1998) 0.82
A detailed study on the effects of protein kinase C activation on alpha-2 adrenoceptor-coupled modulation of norepinephrine release in hippocampus. J Pharmacol Exp Ther (1991) 0.82
Neurons are generated in confluent astroglial cultures of rat neonatal neocortex. Neuroscience (1997) 0.82
Detection and characterisation of neurotransmitters, particularly peptides, in the gastrointestinal tract. Scand J Gastroenterol Suppl (1982) 0.82
CCK-containing terminals in the hippocampus are derived from intrinsic neurons: an immunohistochemical and radioimmunological study. Brain Res (1981) 0.82
3,4-Diaminopyridine-induced noradrenaline release from CNS tissue as a model for action potential-evoked transmitter release: effects of phorbol ester. Eur J Pharmacol (1989) 0.82
Phorbol ester-mediated enhancement of hippocampal noradrenaline release: which ion channels are involved? Eur J Pharmacol (1988) 0.82
Influence of serotonin on water intake and the renin-angiotensin system in the rat. Arch Int Pharmacodyn Ther (1974) 0.81
Possible involvement of protein kinase C (PKC) in the regulation of electrically evoked serotonin (5-HT) release from rabbit hippocampal slices. Eur J Pharmacol (1987) 0.81
Evidence for inhibition by beta-endorphin of vasopressin release during foot shock-induced stress in the rat. Neuroendocrinology (1982) 0.81
Naloxone promotes stimulus-evoked vasopressin release in vivo. Eur J Pharmacol (1980) 0.81
Potential anticonvulsive properties of endogenous prostaglandins formed in mouse brain. Brain Res (1982) 0.81
Vasopressin and beta-endorphin release after osmotic and non-osmotic stimuli: effect of naloxone and dexamethasone. Eur J Pharmacol (1982) 0.81
Dopamine modulates cholecystokinin release in neostriatum. Nature (1983) 0.81
Dopaminergic modulation of hippocampal noradrenaline release. Evidence for alpha 2-antagonistic effects of some dopamine receptor agonists and antagonists. Naunyn Schmiedebergs Arch Pharmacol (1985) 0.81
Zopiclone improves sleep quality and daytime well-being in insomniac patients: comparison with triazolam, flunitrazepam and placebo. Int Clin Psychopharmacol (1994) 0.81
P2 purinoceptors modulating noradrenaline release from sympathetic neurons in culture. Eur J Pharmacol (1994) 0.81
Staurosporine counteracts the phorbol ester-induced enhancement of neurotransmitter release in hippocampus. Arch Int Pharmacodyn Ther (1989) 0.80
Physiological Adjustments in Chloride Balance of the Goldfish. Science (1948) 0.80
Cholecystokinin-like immunoreactivity of rat medial basal hypothalamus: investigations on a possible hypophysiotropic function. Neuroendocrinology (1983) 0.80
Studies on cholecystokinin-containing neuronal pathways in rat cerebral cortex and striatum. Ann N Y Acad Sci (1985) 0.80